Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_1
3
60%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (75.0%)
Phase 31 (25.0%)

Trials by Status

completed480%
suspended120%

Recent Activity

0 active trials
Showing 5 of 5
completed

Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients

NCT04128878
completedphase_1

Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects

NCT01873950
completedphase_1

Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block

NCT02308748
completedphase_1

Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults

NCT02365532
suspendedphase_3

High Intensity Focused Ultrasound (HIFU) Ablation System Study

NCT00392106

Clinical Trials (5)

Showing 5 of 5 trials
NCT04128878

Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients

Completed
NCT01873950Phase 1

Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects

Completed
NCT02308748Phase 1

Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block

Completed
NCT02365532Phase 1

Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults

Completed
NCT00392106Phase 3

High Intensity Focused Ultrasound (HIFU) Ablation System Study

Suspended

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5